Search

Your search keyword '"Susen, Sophie"' showing total 749 results

Search Constraints

Start Over You searched for: Author "Susen, Sophie" Remove constraint Author: "Susen, Sophie"
749 results on '"Susen, Sophie"'

Search Results

1. Definitions of major bleeding for predicting mortality in critically ill adult patients who survived 24 hours while supported with peripheral veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: a comparative historical cohort study

3. The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia

4. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)

5. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs

8. A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD

10. Inflammatory markers and auto-Abs to type I IFNs in COVID-19 convalescent plasma cohort study

11. Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis

13. ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation

14. Tranexamic acid dose–response relationship for antifibrinolysis in postpartum haemorrhage during Caesarean delivery: TRACES, a double-blind, placebo-controlled, multicentre, dose-ranging biomarker study

15. Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition

17. Définitions de l’hémorragie majeure pour prédire la mortalité chez la patientèle adulte gravement malade ayant survécu 24 heures sous oxygénation par membrane extracorporelle veino-artérielle périphérique pour un choc cardiogénique : une étude de cohorte historique comparative

18. Prévention du risque thromboembolique veineux et surveillance de l’hémostase chez les patients hospitalisés pour COVID-19 : propositions réactualisées (avril 2021). Groupe d’intérêt en hémostase périopératoire (GIHP) et groupe d’étude sur l’hémostase et la thrombose (GFHT)

20. Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)

23. Diagnosis and management of heparin-induced thrombocytopenia

26. P-237 La formation aux bonnes pratiques transfusionnelles et au logiciel eTraceLine des personnels médicaux et paramédicaux du CHU de Lille

27. Shear Forces Induced Platelet Clearance Is a New Mechanism of Thrombocytopenia

29. Von Willebrand disease type 2B with a novel mutation in the VWF gene

32. Position du GIHP sur les tests viscoélastiques : quelle place pour quelle indication en situation hémorragique ?

33. Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d’intérêt en hémostase périopératoire (GIHP) et du Groupe français d’études sur l’hémostase et la thrombose (GFHT) en collaboration avec la Société française d’anesthésie-réanimation (SFAR)

35. Primary Hemostatic Disorders and Late Major Bleeding After Transcatheter Aortic Valve Replacement

36. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19

37. Human Aortic Valve Interstitial Cells Display Proangiogenic Properties During Calcific Aortic Valve Disease

39. Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive Care Medicine (SFAR)

40. Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) – September 2016

42. Arterial Pulsatility and Circulating von Willebrand Factor in Patients on Mechanical Circulatory Support

43. Management of antiplatelet therapy in patients undergoing elective invasive procedures: Proposals from the French Working Group on perioperative hemostasis (GIHP) and the French Study Group on thrombosis and hemostasis (GFHT). In collaboration with the French Society for Anesthesia and Intensive Care (SFAR)

47. Development of a Decision Support Tool for Anticoagulation in Critically Ill Patients Admitted for SARS-CoV-2 Infection: The CALT Protocol

48. Endotheliopathy Is Induced by Plasma From Critically Ill Patients and Associated With Organ Failure in Severe COVID-19

49. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) – September 2015

Catalog

Books, media, physical & digital resources